Department of Defense (DoD) Peer Reviewed Cancer Research Program (PRCRP): Idea Award with Special Focus

The DoD Peer Reviewed Cancer Research Program Idea Award with Special Focus supports innovative, untested, high-risk/potentially high-reward concepts, theories, paradigms, and/or methods in cancer research that are relevant to Service Members, their families, and other military beneficiaries.

To be considered for funding, applications must address at least one of the Topic Areas. Research applications in the areas of breast, prostate, lung (excluding mesothelioma), or ovarian cancer will not be accepted.

    • Colorectal cancer
    • Genetic cancer
    • Kidney cancer
    • Listeria vaccine for cancer
    • Liver cancer (New for FY15)
    • Melanoma and other skin cancers
    • Mesothelioma
    • Myeloproliferative disorders
    • Neuroblastoma
    • Pancreatic cancer
    • Stomach cancer (new for FY15)

Funding & Duration

Maximum funding for the entire period of performance is US$400,000 for direct costs (plus indirect costs). Maximum period of performance is 2 years.


Independent investigator at or above the level of Assistant Professor (or equivalent).

Submission Requirements

Pre-Application must be submitted to the Research Branch for internal review by 25 May 2015. Application submission is by invitation only. Application due for internal review: 18 August 2015.

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at:

Applications must be submitted through the federal government’s single-entry portal,

Submitted applications must be accompanied by a signed and completed copy of the University’s Grant Application Cover Sheet. Submissions may be emailed to the Research Branch unless otherwise specified.

Grants Officer: Dr Don McMaster


Further Information

This entry was posted in Funding by Award Type, Grants (Project Funds), Health & Medical Sciences, International Funding and tagged . Bookmark the permalink.

Comments are closed.